Approved therapyApproved treatment

Understanding Real-World Use of Trofinetide for Rett Syndrome

This study looked at how people with Rett syndrome in the United States used trofinetide, an FDA-approved treatment, over time.

Educational summary - not medical advice. Always consult your child's care team.
Rett SyndromeMedication·

Research Profile

Source:Journal of medical economics

Published: July 23, 2026

Added to SpecialCircle: June 22, 2026

Evidence Level

Approved therapy

Research Status

Approved treatment

Key takeaways

  • •Trofinetide is the only FDA-approved medication for Rett syndrome.
  • •More than half (54.9%) of individuals stayed on trofinetide treatment for at least 14 months.
  • •Individuals who consistently took trofinetide generally maintained stable dosing patterns.
  • •Older age and a history of infectious disorders were linked to individuals stopping treatment.
  • •About 7.6% of those who stopped treatment later restarted it.

Source

Journal of medical economics · Peer-reviewed study

Read the original source

Plain-language summary

This research explored how people with Rett syndrome actually use trofinetide, the only FDA-approved medication for the condition, in their daily lives. Researchers looked back at health insurance claims data from April 2023 to March 2024 to understand how long individuals stayed on the medication, their dosing patterns, and what might lead some to stop.

They found that many individuals continued treatment for over a year, often with stable dosing. However, some factors like older age or past infections were associated with stopping the medication.

Why parents may care

This study provides insights into how real families use an FDA-approved medication for Rett syndrome. Understanding how long people typically stay on the treatment and what factors might influence stopping or restarting can be helpful when discussing treatment plans with doctors.

It also highlights the importance of consistent dosing for those who continue treatment.

What this means for daily life

For families, this research suggests that staying on trofinetide consistently might involve maintaining stable medication doses. Awareness of factors like age and infectious disorders that could affect treatment persistence might help families anticipate and discuss potential challenges with their healthcare team.

What is still unknown

This study looked at how people used trofinetide but did not explore the reasons why individuals became non-persistent, beyond identifying associations like age and infectious disorders. It also did not cover the effects of treatment on symptoms or quality of life during the study period.

More research could look into the specific clinical outcomes related to persistence and dosing patterns.

Frequently asked questions about Rett Syndrome

Trofinetide is the first and only medication approved by the FDA for the treatment of Rett syndrome. This study examined how it's used in real-world settings.

Terminology glossary

Rett syndrome
A rare genetic neurological disorder that affects girls almost exclusively, leading to severe impairments in movement, communication, and learning.
Trofinetide (TROF)
A medication that is the first and only FDA-approved pharmacologic treatment specifically for Rett syndrome.
FDA-approved
Means that the U.S. Food and Drug Administration has determined that the drug is safe and effective for its intended use.
Real-world evidence
Information about how a treatment works in typical patient care settings, rather than in highly controlled research studies.
Non-persistence
Refers to when a person stops taking a prescribed medication for a period, defined in this study as a gap of more than 90 days in refills.
Retrospective claims analysis
A type of study that looks back at existing data, such as insurance claims, to understand treatment patterns and outcomes.

Questions to ask your doctor or therapist

  • ?What are common reasons for stopping trofinetide treatment that I should be aware of?
  • ?How important is consistent dosing of trofinetide for my child's treatment plan?
  • ?Are there specific situations, like infections, where we might need to adjust our child's trofinetide plan?
  • ?What kind of monitoring is done to ensure appropriate dosing of trofinetide?

⚕️ This research digest is for educational and community support purposes only. It is not medical advice, diagnosis, or treatment. Always speak with a qualified doctor, therapist, or medical professional before making decisions about care.

Related research

Understanding Who Receives Trofinetide for Rett Syndrome in the U.S.

A study found that only about one-quarter of eligible individuals with Rett Syndrome received the newly approved medication, Trofinetide, shortly after its approval in the United States.

Update on the NGN-401 Gene Therapy Study

Researchers have finished giving the study treatment to all 25 children in a major trial for a new gene therapy called NGN-401.

Understanding Sleep Challenges and Daytime Behavior in Rett Syndrome

A recent review explains how sleep disturbances are common in Rett Syndrome and how they relate to a child's mood and behavior during the day.

Review of New Disease-Modifying Treatments for Rett Syndrome

A recent review for doctors highlights how new gene-based therapies are changing the way Rett Syndrome is managed.

Talk to parents who truly understand

SpecialCircle is a free, private community. Ask questions, share what works, and never feel alone.

Find parents who understand Ask the community